The 2018 permanent authorization of dual-eligible special needs plans marked a significant long-term commitment by policy makers and coincided with substantial growth in plan offerings and enrollment.
Helen M. Parsons, PhD, MPH
Advertisement
Articles by Helen M. Parsons, PhD, MPH
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol
2
Cardiology Prices Vary Widely by Insurer and State
3
Medicaid MFN Pricing Could Save $8.6 Billion
4
CRC Treatment Delays Linked to Higher Metastasis Risk, Supporting Pathway-Specific Benchmarks
5